Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for idiopathic multidrug-resistant nephrotic syndrome has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for idiopathic multidrug-resistant nephrotic syndrome.
3 publications have been identified in PubMed for idiopathic multidrug-resistant nephrotic syndrome. Research spans Diagnostic / Biomarker (33%), Review / Meta-Analysis (33%), and Case Report / Case Series (33%).
Bukoska A (2026). [PMID: 41921043](https://pubmed.ncbi.nlm.nih.gov/41921043/). *J Nephrol*. [Case Report / Case Series]
Mühlig AK (2026). [PMID: 42026266](https://pubmed.ncbi.nlm.nih.gov/42026266/). *Pediatr Nephrol*. [Review / Meta-Analysis]
Hengel FE (2025). [PMID: 39922375](https://pubmed.ncbi.nlm.nih.gov/39922375/). *Kidney Int*. [Diagnostic / Biomarker]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 9:07 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center